102153-47-9 Usage
Uses
Used in Pharmaceutical Industry:
3-bromo-1-nitronaphthalene is used as a synthetic intermediate for the production of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-bromo-1-nitronaphthalene is employed as a building block for the synthesis of agrochemicals. Its properties make it suitable for the creation of compounds that can be used in pest control and crop protection, thereby enhancing agricultural productivity.
Used in Organic Synthesis:
3-bromo-1-nitronaphthalene is utilized as a versatile intermediate in organic synthesis. Its reactivity and structural features make it a valuable precursor for the preparation of a wide range of organic compounds, which can be further utilized in various chemical and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 102153-47-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,2,1,5 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 102153-47:
(8*1)+(7*0)+(6*2)+(5*1)+(4*5)+(3*3)+(2*4)+(1*7)=69
69 % 10 = 9
So 102153-47-9 is a valid CAS Registry Number.
102153-47-9Relevant academic research and scientific papers
TARGETED RADIOPHARMACEUTICALS FOR THE DIAGNOSIS AND TREATMENT OF PROSTATE CANCER
-
Page/Page column 329; 330, (2021/01/29)
A compound of general formula (I): wherein: n is 1, 2 or 3; R1, R2, R3 and R4, independently represent OH or Q; and 20 Q represents a tissue-targeting moeity selected from the group consisting of or a stereoisomer, a hydrate, a solvate, or a salt thereof, or a mixture of same, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said 25 compounds for manufacturing pharmaceutical compositions for the treatment or prophylaxis of diseases, in particular of soft tissue diseases, as a sole agent or in combination with other active ingredients.
